Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Revenue | 34M | 46M | 40M | 32M | 54M | 52M |
| Cost of revenue | 18M | 27M | 24M | 17M | 35M | 33M |
| Gross profit | 17M | 19M | 17M | 15M | 19M | 19M |
| Research and development | 6M | 5M | 5M | 5M | 5M | 5M |
| Selling, general and administrative | 7M | 6M | 5M | 4M | 5M | 4M |
| Operating expenses | 20M | 17M | 15M | 15M | 18M | 17M |
| Operating income | −4M | 2M | 1M | −424,000 | 1M | 2M |
| Pre-tax income | −5M | 1M | 529,000 | −1M | 8M | 197,000 |
| Income tax | 34,000 | −36,000 | 22,000 | 23,000 | 36,000 | 118,000 |
| Net income | −5M | 1M | 507,000 | −2M | 9M | 624,000 |
| Earnings per share | 0.66 | 0.03 | −0.03 | −0.16 | 0.66 | −0.02 |
| Earnings per share, diluted | 0.65 | 0.03 | −0.03 | −0.16 | −0.06 | −0.02 |
| Weighted average shares | 16M | 15M | 15M | 15M | 12M | 12M |
| Weighted average shares, diluted | 16M | 16M | 15M | 15M | 13M | 12M |
| Metric | 31/03/2026 | 31/12/2025 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 31/12/2024 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 19M | 25M | 15M | 13M | 35M | 40M | 12M | 43M |
| Receivables | 16M | 25M | 28M |
| Metric | 31/03/2026 | 30/09/2025 | 30/06/2025 | 31/03/2025 | 30/09/2024 | 30/06/2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 2M | — | — | −3M | — | — |
| Depreciation and amortisation | 2M | 2M | 2M | 2M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 24M |
| 12M |
| 14M |
| 16M |
| 21M |
| Inventory | 13M | 8M | 9M | 15M | 15M | 14M | 18M | 18M |
| Current assets | 53M | 64M | 57M | 56M | 66M | 73M | 85M | 93M |
| Goodwill | 4M | 4M | 4M | 4M | 4M | 4M | 4M | 22M |
| Total assets | 84M | 94M | 86M | 83M | 93M | 100M | 113M | 150M |
| Current liabilities | 52M | 48M | 44M | 46M | 59M | 63M | 189M | 239M |
| Short-term debt | — | — | — | — | — | — | 6M | 14M |
| Total liabilities | 110M | 98M | 94M | 94M | 106M | 113M | 198M | 251M |
| Equity | −25M | −4M | −8M | −10M | −13M | −13M | −85M | −102M |
| Shares outstanding | 16M | 15M | 15M | 15M | 15M | 15M | 13M | 12M |
| Shares issued | 16M | 15M | 15M | 15M | 15M | 15M | 13M | 12M |
| 3M |
| 4M |
| Share-based compensation | 2M | — | — | 2M | — | — |
| Capital expenditure | 131,000 | — | — | 32,000 | — | — |
| Investing cash flow | −4M | — | — | −1M | — | — |
| Financing cash flow | −3M | — | — | 42,000 | — | — |